Cancer vaccines.

Journal Article (Journal Article)

Given the renewed interest in vaccine development sparked by the COVID-19 pandemic, we are revisiting the current state of vaccine development for cancer prevention and treatment. Experts discuss different vaccine types, their antigens and modes of action, and where we stand on their clinical development, plus the challenges we need to overcome for their broad implementation.

Full Text

Duke Authors

Cited Authors

  • Schiller, JT; Lowy, DR; Frazer, IH; Finn, OJ; Vilar, E; Lyerly, HK; Gnjatic, S; Zaidi, N; Ott, PA; Balachandran, VP; Dietrich, P-Y; Migliorini, D; Vonderheide, RH; Domchek, SM

Published Date

  • June 13, 2022

Published In

Volume / Issue

  • 40 / 6

Start / End Page

  • 559 - 564

PubMed ID

  • 35700704

Pubmed Central ID

  • PMC9190070

Electronic International Standard Serial Number (EISSN)

  • 1878-3686

Digital Object Identifier (DOI)

  • 10.1016/j.ccell.2022.05.015


  • eng

Conference Location

  • United States